NVDA
61
-3
DE
58
-7
BDX
63
7
PRGO
31
6
GWW
57
-3
MRO
70
3
MCO
64
2
EOG
55
3
GPC
66
5
MTCH
30
-4
DFS
33
3
CVX
44
3
EL
21
3
RRC
70
2
HES
70
2
FOX
24
-13
UA
39
4
RIG
64
6
AMT
30
-2
COF
43
3
NVDA
61
-3
DE
58
-7
BDX
63
7
PRGO
31
6
GWW
57
-3
MRO
70
3
MCO
64
2
EOG
55
3
GPC
66
5
MTCH
30
-4
DFS
33
3
CVX
44
3
EL
21
3
RRC
70
2
HES
70
2
FOX
24
-13
UA
39
4
RIG
64
6
AMT
30
-2
COF
43
3
Financhill
Back

Bio-Techne 10K Form

Sell
38

TECH
Bio-Techne

Last Price:
78.73
Seasonality Move:
5.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-26 10K TECH/Bio-Techne Annual
2020-05-11 10Q TECH/Bio-Techne Quarterly
2020-02-06 10Q TECH/Bio-Techne Quarterly
2019-11-06 10K TECH/Bio-Techne Annual
2019-10-09 10K TECH/Bio-Techne Annual
2019-08-28 10K TECH/Bio-Techne Annual

Receive TECH News And Ratings

See the #1 stock for the next 7 days that we like better than TECH

TECH Financial Statistics

Sales & Book Value

Annual Sales: $1.14B
Cash Flow: $72.56M
Price / Cash Flow: 59
Annual Sales: $12.47
Price / Book: 6.34

Profitability

EPS (TTM): 1.76250
Net Income (TTM): $285.26M
Gross Margin: $769.82M
Return on Equity: 15.61%
Return on Assets: 11.65%

Bio-Techne Earnings Forecast

Key Bio-Techne Financial Ratios

  • The Gross Profit Margin over the past 35 years for TECH is 67.72%.
  • The Selling, General & Administrative Expenses for TECH have been equal to 31.01% of Gross Profit Margin.
  • The Research & Development expenses have been 8.14% of Revenue.
  • The Interest Expense is 3.93% of Operating Income.
  • The Net Earning history of TECH is 25.10% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 21 years.

Bio-Techne Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: TECH
CUSIP: 09073M
Website: bio-techne.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 4.84
Quick Ratio: 3.29

Price-to-Earnings

Trailing P/E Ratio: 44.75
Forward P/E Ratio: 33.8

TECH Technical Analysis vs Fundamental Analysis

Sell
38
Bio-Techne (TECH) is a Sell

Is Bio-Techne a Buy or a Sell?

  • Bio-Techne stock is rated a Sell
    The current Bio-Techne [TECH] share price is $78.76. The Score for TECH is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.